PAK1 Signaling in Cancer: Multifaceted Roles and Therapeutic Implications

Faiz Meman1, Divya Tandel1, Archana Navale1

  • 1Department of Pharmacology, Parul Institute of Pharmacy, Parul University, Limda, Waghodia, Vadodara, Gujarat, India.

Current Gene Therapy
|August 5, 2025
PubMed

Insights

p21-activated kinase 1 (PAK1) is crucial in cancer progression, affecting cell growth, blood vessel formation, and metastasis. Understanding PAK1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • p21-activated kinase 1 (PAK1) is a serine-threonine kinase.
  • PAK1 functions as a downstream effector for Rho GTPases like Rac, Ras, and CDC42.
  • These GTPases are critical regulators in numerous oncogenic signaling pathways.

Purpose of the Study:

  • To elucidate the multifaceted roles of PAK1 in cancer biology.
  • To highlight PAK1's significance in key oncogenic signaling pathways.
  • To underscore PAK1 as a potential therapeutic target for cancer intervention.

Main Methods:

  • Review and synthesis of existing literature on PAK1.
  • Analysis of PAK1's involvement in cellular processes.
  • Examination of PAK1's influence on therapeutic resistance.

Main Results:

  • PAK1 is implicated in cell cycle regulation, angiogenesis, and metastasis.
  • PAK1 plays a role in the development of therapeutic resistance in various cancers.
  • PAK1 acts as a central node in diverse signaling pathways driving cancer progression.

Conclusions:

  • Comprehensive understanding of PAK1's functions is vital for cancer research.
  • PAK1 represents a promising target for developing novel cancer therapies.
  • Targeted interventions focusing on PAK1 may improve cancer diagnostics and treatment outcomes.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K